Ontario man says medication he's been taking for a decade just quadrupled in price
An Ontario man with Duchenne muscular dystrophy said he was shocked when he got his latest prescription filled for a medication he has been taking for the past ten years.
“I couldn’t believe it. I need to take this medication to help my muscles be able to work a bit better and it has almost quadrupled in price,” said 21-year-old Arun Crishanth of Aurora.
The medication is Deflazacort, a popular drug used to treat Duchenne muscular dystrophy, however it is not covered under government health plans.
The drug is a steroid taken daily to help keep muscles strong and symptoms of muscular dystrophy in check.
Crishanth said he used to get a four month supply of Deflazacort for $187, but when he got his last prescription filled it jumped to $666.
Crishanth was told by his pharmacy Pharmasave that the price increase was due to it being manufactured by a new drug company.
“This new company decided to turn around and quadruple the price. To me it seems ridiculous that they can increase the price that much," said Crishanth.
CTV News Toronto reached out to Pharmasave and a spokesperson said, “Pharmacy pricing in Canada is linked to the cost to purchase the medication from the manufacturer or distributor. The increased pricing experienced by pharmacies (and thus also to patients) is due to manufacturer and distributor changes.”
Deflazacort, a popular drug used to treat Duchenne muscular dystrophy, is photographed.
CTV News Toronto also reached out to Muscular Dystrophy Canada and its CEO Stacey Lintern said in a statement, “Many individuals and their families have been advised by their doctors that Deflazacort is the most suitable option due to its minimal side effects, with some individuals having been on this treatment for 15 years or more. However, the significant increase in price will have detrimental effects on these individuals and their families.”
CTV News Toronto was unable to reach the new manufacturer of Deflazacourt, however Muscular Dystrophy Canada confirmed the price increase was due to a new manufacturer making the drug in Europe which also means increased shipping costs.
While there are cheaper alternatives, they have side effects and many patients with Duchenne muscular dystrophy feel that Deflazacourt is the preferred treatment.
"It’s a drug I’ve been taking for so many years, since I was 10 years old," said Crishanth, who said the drug will now cost him almost $2,000 a year.
"Obviously they should not be able to increase prices like that. It clearly isn't because of inflation, this is just to make some money and I think it's ridiculous that that can happen," said Crishanth.
Muscular Dystrophy Canada said it's important for patients to have equal access to appropriate treatments at a fair cost and that they will continue to try and influence change with regards to the price hike.
If you or your child is experiencing challenges accessing Deflazacort, you can contact Muscular Dystrophy Canada at research@muscle.ca or call 1-800-567-2873 ext. 1114.
CTVNews.ca Top Stories

NDP to form majority government following historic Manitoba election
Wab Kinew’s New Democratic Party is projected to have enough seats in the Manitoba Legislature to form a majority government, taking the helm after two consecutive terms of a majority Tory regime.
Parks Canada reveals additional details about deadly bear attack in Banff
The couple and dog mauled and killed by a grizzly bear in the backcountry of Banff National Park late last week did everything right, Parks Canada says.
Parents want arrest after son 'deliberately kicked' in neck during Edmonton hockey game
A Junior C hockey player says he is lucky to be alive after his neck was sliced open by a hockey skate last week in an act his parents believe – and the referee ruled – was an intentional kick.
A look back at election day in Manitoba
Manitobans have cast their vote in a historic election. The CTV News Decision Desk has declared an NDP majority win, making NDP Leader and Premier-elect Wab Kinew the first First Nations premier in the province. Take a look at the election night in Manitoba.
Multiple people have been shot on campus of Morgan State University in Baltimore, police say
Multiple people were shot at Morgan State University in Baltimore on Tuesday, according to police, who urged students to take shelter on the campus of the historically Black college.
Canadian condo sales falling amid concerns over interest rate hikes
Amid consistent interest rate hikes and wavering markets, Canadian condo sales are starting to fall in all but two markets in the nation, according to a new report from Re/Max.
McCarthy becomes the first U.S. speaker ever to be ousted from the job in a House vote
U.S. House Speaker Kevin McCarthy was voted out of the job Tuesday in an extraordinary showdown, a first in U.S. history that was forced by a contingent of hard-right conservatives and threw the House and its Republican leadership into chaos.
Train service restored after CN experiences network-wide system failure
Canadian National Railway Co. experienced a network-wide system failure on Tuesday that affected Via, GO and other trains in Ontario. The issue was resolved and service was restored Tuesday night.
Tropical Storm Philippe could impact the Maritimes on Thanksgiving weekend
The Maritimes have been on an extended run of very fair weather the last two weeks while under a persistent ridge of high pressure. Unfortunately, that pattern changes this weekend with the approach of a weather front from the west and a likely post-tropical storm Philippe from the south.